Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Introduction
Electrochemical biosensors are analytical devices used to provide analytical information by biological sample, such as tissues, enzymes and whole cell, to an electrical signal. It is cost effective, user friendly, simple, disposable and convenient. Potentiometric sensors, amperometric sensors and conductometric sensor are detection modes of electrochemical detection. It is used mostly in miniaturized devices and is used for the detection of biological and non-biological matrices.
The global electrochemical biosensors market is expected to reach USD 23,707.2 million by 2022 at a CAGR of 9.7% during the forecast period.
The global electrochemical biosensors by applications is segmented into diagnosis, patient monitoring and others. Diagnosis segment accounted for the largest market by application. The major factor that influence the growth of the market are the need for analyses in the clinical area with reliable analytical methods and devices. Diagnosis segment accounted for the largest market share of around 54.1% in 2016, and is anticipated to grow at a CAGR of 9.5% during the forecasted period 2016-2022.
The global electrochemical biosensors by end user is majorly segmented into point of care testing, diagnostics center, research laboratories and others. The point of care segment holds the largest market by end user in 2016. Point of care testing segment accounted for the largest market share of around 45.2% in 2016, with a market value of USD 5,521.9 million and is anticipated to grow at a CAGR of 9.9% during the forecasted period 2017-2022.
On the basis of regions, the market is segmented into North America, Europe, Asia-Pacific and the Middle East & Africa. North America accounted for the largest market share of 43.0% in 2016, with a market value of USD 5,251.5 million and is projected to grow at a CAGR of 9.4% during the forecast period. Europe was the second-largest market in 2016, valued at USD 3,690.5 million in 2016; it is projected to grow at a CAGR of 9.8%. However, Asia Pacific is projected to grow at the highest CAGR of 10.0%.
Key Players
The leading market players in the global electrochemical biosensors market include: F. Hoffmann-La Roche AG, Medtronics, Bayer AG, Abbott Laboratories, I-SENS, Inc, Siemens Healthcare GmbH and others.
Study objectives
• Providing a detail analysis of the electrochemical biosensors market structure along with forecast for the next 7 years related to various segments and sub-segments of the market.
• Giving insights about factors affecting the market growth.
• Analyzing the market based on various analysis which includes price analysis, supply chain analysis, Porters Five Force analysis etc.
• Giving the past revenue and estimated future revenue of the market’s segments and sub-segments with respect to the main market and small scale market of the same present globally.
• Giving regional level analysis of the market with respect to the current market size and future growth prospect of the same.
• Giving regional level analysis of the market with respect to segments which includes by application and by end user also giving regional level analysis of the market’s sub-segments.
• Providing an overview of key players and their strategic profiling in the market; comprehensively analyzing their core competencies and drawing the market’s competitive structure.
• Tracking and analyzing competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments along with research and developments taking place in the global Electrochemical biosensors market
Target Audience
• Electrochemical biosensors manufacturers
• Pharmaceutical companies
• Biotechnology companies
• Academic research institutes
• Government institutes
Key Findings
• Diagnosis segment accounted for the largest market share of around 54.1% in 2016, with a market value of USD 6,600 million and is anticipated to grow at a CAGR of 9.5% during the forecasted period 2016-2022.
• Point of care testing segment accounted for the largest market share of around 45.2% in 2016, with a market value of USD 5,521.9 million and is anticipated to grow at a CAGR of 9.9% during the forecasted period 2017-2022
• North America accounted for the largest market share of 43.0% in 2016, with a market value of USD 5,251.5 million and is projected to grow at a CAGR of 9.4% during the forecast period
The reports also covers regional analysis
• North America
o US
o Canada
• Europe
o Germany
o France
o U.K.
o Italy
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Republic of Korea
o Rest of Asia-Pacific
• Middle East & Africa
o Middle East
o Africa
Electrochemical biosensors are analytical devices used to provide analytical information by biological sample, such as tissues, enzymes and whole cell, to an electrical signal. It is cost effective, user friendly, simple, disposable and convenient. Potentiometric sensors, amperometric sensors and conductometric sensor are detection modes of electrochemical detection. It is used mostly in miniaturized devices and is used for the detection of biological and non-biological matrices.
The global electrochemical biosensors market is expected to reach USD 23,707.2 million by 2022 at a CAGR of 9.7% during the forecast period.
The global electrochemical biosensors by applications is segmented into diagnosis, patient monitoring and others. Diagnosis segment accounted for the largest market by application. The major factor that influence the growth of the market are the need for analyses in the clinical area with reliable analytical methods and devices. Diagnosis segment accounted for the largest market share of around 54.1% in 2016, and is anticipated to grow at a CAGR of 9.5% during the forecasted period 2016-2022.
The global electrochemical biosensors by end user is majorly segmented into point of care testing, diagnostics center, research laboratories and others. The point of care segment holds the largest market by end user in 2016. Point of care testing segment accounted for the largest market share of around 45.2% in 2016, with a market value of USD 5,521.9 million and is anticipated to grow at a CAGR of 9.9% during the forecasted period 2017-2022.
On the basis of regions, the market is segmented into North America, Europe, Asia-Pacific and the Middle East & Africa. North America accounted for the largest market share of 43.0% in 2016, with a market value of USD 5,251.5 million and is projected to grow at a CAGR of 9.4% during the forecast period. Europe was the second-largest market in 2016, valued at USD 3,690.5 million in 2016; it is projected to grow at a CAGR of 9.8%. However, Asia Pacific is projected to grow at the highest CAGR of 10.0%.
Key Players
The leading market players in the global electrochemical biosensors market include: F. Hoffmann-La Roche AG, Medtronics, Bayer AG, Abbott Laboratories, I-SENS, Inc, Siemens Healthcare GmbH and others.
Study objectives
• Providing a detail analysis of the electrochemical biosensors market structure along with forecast for the next 7 years related to various segments and sub-segments of the market.
• Giving insights about factors affecting the market growth.
• Analyzing the market based on various analysis which includes price analysis, supply chain analysis, Porters Five Force analysis etc.
• Giving the past revenue and estimated future revenue of the market’s segments and sub-segments with respect to the main market and small scale market of the same present globally.
• Giving regional level analysis of the market with respect to the current market size and future growth prospect of the same.
• Giving regional level analysis of the market with respect to segments which includes by application and by end user also giving regional level analysis of the market’s sub-segments.
• Providing an overview of key players and their strategic profiling in the market; comprehensively analyzing their core competencies and drawing the market’s competitive structure.
• Tracking and analyzing competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments along with research and developments taking place in the global Electrochemical biosensors market
Target Audience
• Electrochemical biosensors manufacturers
• Pharmaceutical companies
• Biotechnology companies
• Academic research institutes
• Government institutes
Key Findings
• Diagnosis segment accounted for the largest market share of around 54.1% in 2016, with a market value of USD 6,600 million and is anticipated to grow at a CAGR of 9.5% during the forecasted period 2016-2022.
• Point of care testing segment accounted for the largest market share of around 45.2% in 2016, with a market value of USD 5,521.9 million and is anticipated to grow at a CAGR of 9.9% during the forecasted period 2017-2022
• North America accounted for the largest market share of 43.0% in 2016, with a market value of USD 5,251.5 million and is projected to grow at a CAGR of 9.4% during the forecast period
The reports also covers regional analysis
• North America
o US
o Canada
• Europe
o Germany
o France
o U.K.
o Italy
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Republic of Korea
o Rest of Asia-Pacific
• Middle East & Africa
o Middle East
o Africa
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
